Renovorx to present at the roth mkm healthcare opportunities conference on october 12, 2023

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced that ceo, shaun bagai, will present at the roth mkm healthcare opportunities conference in new york on october 12, 2023. register here. moderated by scott henry, managing director, senior research analyst & head of pharmaceuticals research at roth capital partners, llc, will conduct a fireside c.
RNXT Ratings Summary
RNXT Quant Ranking